Pharmacy Benefit Management

From Specialty Pharmacy News - Although limited-distribution arrangements are not new to the specialty drug arena, one manufacturer’s changes to how its specialty pharmaceuticals are distributed are prompting outcries from providers and hospitals. In the latest development, a group of executives from academic medical centers are urging Congress to review the switch by manufacturer Genentech, Inc. Read more

From Drug Benefit News - Contrave (naltrexone HCl and bupropion HCl) last month joined the growing category of anti-obesity medications available by prescription in the U.S. (DBN 10/24/14, p. 8). Read more

Pharmacy Benefit Management Blog

By Angela Maas - December 16, 2014
When the Biologics Price Competition and Innovation Act passed as part of the health reform law, it established a pathway by which biosimilar drugs could gain abbreviated approval by the FDA. But beyond creating that pathway, little else about the process was laid out in the law, leaving the...
By Lauren Flynn Kelly - December 12, 2014
One of the hottest pharmaceutical topics in recent months has been generic drug price inflation. Half of all retail generic drugs rose in price over the last year, according to Drug Channels. Sen. Bernie Sanders (I-Vt.), chairman of the Senate Subcommittee on Primary Health and Aging, has attempted...
By Lauren Flynn Kelly - November 21, 2014
The topic of formulary exclusions has been getting a lot of attention lately and was the subject of a panel discussion at last week’s National Business Coalition on Health conference that raised a lot of good questions and considerations for plan sponsors. For example, employers wonder whether...

It's quick and easy to sign up for FREE access to!

Why do I need to register?